Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 03 Sep 2015  |  Asia Pacific  |  Market Research

    Impact of Policies Shaping ASEAN Healthcare—Outlook till 2020

    Policies Raising Standards and Lowering Barriers Across ASEAN

    The research service provides an analysis of the policies impacting the healthcare market in the Association of Southeast Asian Nations (ASEAN). It includes the current trends, market size, revenue forecast, and market drivers and restraints. Healthcare market participants and key opinion leaders were interviewed to obtain their perception about tr...

    $2,450.00
  2. 28 Sep 2015  |  Asia Pacific  |  Market Research

    End-User Perspectives on the SEA RIS/ PACS Market

    Next-generation Imaging IT Needs Will Focus on Interoperability

    Picture archiving communication systems (PACS) were a real game changer 3 decades ago when, in combination with radiology information systems (RIS), they enabled rapid digitalization of medical imaging data. Today, Southeast Asia again stands at the brink of transformation as RIS PACS enter their second or third generation of deployment. In an effo...

    $4,950.00
  3. 11 Nov 2015  |  Asia Pacific  |  Market Research

    Asia-Pacific Point-of-Care Testing Market

    Trends, Challenges, and Best Practices for Stakeholders

    Asia-Pacific (APAC) point-of-care testing (POCT) market was worth $2.80 billion in 2014. In hospitals, POC is used more in emergency rooms (ERs), operation theatres (OTs), recovery rooms (RRs), cath labs, and intensive care units (ICU). The rental model in which the cost of the device is borne by the manufacturer while the profit is shared by the h...

    $4,950.00
  4. 08 Dec 2015  |  Asia Pacific  |  Market Research

    A Product and Pipeline Analysis of the Human Plasma-derived Therapeutics Market

    Launch of Novel Immunoglobulin Products and Increasing Awareness of Therapeutic Options to Drive Double-digit Market Growth

    The Chinese pharmaceutical market is expected to be the third-largest in the world in 2013. This research service analyzes various aspects of the Chinese pharmaceutical market between 2007 and 2016. Rising income, improving healthcare infrastructure, and insurance systems are some factors that drive this market. The study discusses in detail the ma...

    $6,000.00
  5. 15 Dec 2015  |  Asia Pacific  |  Market Research

    Analysis of the Medical Imaging Market in Selected ASEAN Countries

    Growth and Trends in CT, MR, PET, and SPECT Modalities

    This research service provides an analysis of the medical imaging market in Indonesia, Malaysia, Singapore, and Thailand. It provides a detailed analysis of current trends, market size, revenue forecasts, and drivers and restraints for the computed tomography (CT), medical resonance (MR), Positron emission tomography (PET), and single-photon emissi...

    $6,000.00